Version 5.4
Bos taurus Protein: LTB
Summary
InnateDB Protein IDBP-685915.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol LTB
Protein Name lymphotoxin beta (TNF superfamily, member 3)
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000027554
InnateDB Gene IDBG-634147 (LTB)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 7 interaction(s) predicted by orthology.
Predicted by orthology
Total 7 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005125 cytokine activity
GO:0005164 tumor necrosis factor receptor binding
GO:0005515 protein binding
Biological Process
GO:0006955 immune response
GO:0010467 gene expression
GO:0043588 skin development
GO:0045084 positive regulation of interleukin-12 biosynthetic process
GO:0048535 lymph node development
Cellular Component
GO:0005615 extracellular space
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR002961 Lymphotoxin-beta
IPR006052 Tumour necrosis factor domain
IPR006053 Tumour necrosis factor
IPR008983 Tumour necrosis factor-like domain
PFAM PF00229
PRINTS PR01237
PR01234
PIRSF
SMART SM00207
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BK50
UniProt Splice Variant
Entrez Gene 529757
UniGene
RefSeq XP_002697417
HUGO HGNC:6711
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02055382
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca